Increase in genetic tests highlights need for oversight

The availability of genetic and genomic tests is increasing at a rapid rate. One of the factors contributing to the explosion of available tests is the relative lack of regulatory oversight of genetic testing in the US. And when that happens, patients can be harmed. One of the areas of greatest expa...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Managed Healthcare Executive 2013-04, Vol.23 (4), p.35
Hauptverfasser:	Hayes, Winifred S, Allingham-Hawkins, Diane
Format:	Artikel
Sprache:	eng
Schlagworte:	Breast cancer Cancer therapies Chemotherapy Colorectal cancer Consumer advertising Disease Genetic testing Genetics Genomics Laboratories Medical equipment Medical tests Meetings Patients Regulation
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!